Sponsor or institution

Clinical trials and research at Fox Chase Cancer Center

• 24Clinical trials
• 1New in 30 days
• 1Country

Newest trials

All recruiting trials (24)

• Bladder cancer: test a biomarker-guided plan after neoadjuvant therapy

  This phase 2 study tests a biomarker- and response-guided plan to preserve the bladder in patients with muscle-invasive bladder cancer after neoadjuvant therapy.

  Recruiting Phase 2 Fox Chase Cancer Center · Philadelphia, Pennsylvania · NCT07908979

• Indirect calorimetry-guided parenteral nutrition in adults with cancer

  This study tests whether using indirect calorimetry to guide parenteral nutrition dosing is feasible and helps cancer patients who can’t meet nutrition needs by eating or tube feeding.

  Recruiting Fox Chase Cancer Center · Philadelphia, Pennsylvania · NCT07776704

• Mycophenolate mofetil with prednisone for immune-related hepatitis from cancer therapy

  This study tests whether starting mycophenolate mofetil plus prednisone can help liver inflammation caused by immune checkpoint inhibitors in adults with moderate to severe immune-related hepatitis.

  Recruiting Phase 2 Fox Chase Cancer Center · Philadelphia, Pennsylvania · NCT07663422

• Prehabilitation before high-risk cancer surgery

  This trial tests a multidisciplinary prehabilitation program to see if it helps adults with cancer recover better after major abdominal surgery.

  Recruiting Fox Chase Cancer Center · Philadelphia, Pennsylvania · NCT07638410

• Neoadjuvant CADI-05 with pembrolizumab for resectable locally advanced head and neck squamous cell carcinoma

  This will test whether adding weekly CADI-05 skin injections to pembrolizumab before surgery helps adults with resectable locally advanced head and neck squamous cell cancer.

  Recruiting at 2 sites Phase 1 Fox Chase Cancer Center · Philadelphia, Pennsylvania and 1 other locations · NCT07455032

• Pembrolizumab maintenance after initial enfortumab vedotin plus pembrolizumab for frontline metastatic urothelial cancer

  This trial will test whether continuing pembrolizumab after an 18-week course of enfortumab vedotin plus pembrolizumab helps people with previously untreated metastatic urothelial carcinoma.

  Recruiting Phase 2 Fox Chase Cancer Center · Philadelphia, Pennsylvania · NCT07221942

• Adaptive radiation boost to try to preserve the rectum in people with rectal adenocarcinoma

  This trial tries adding an MRI-guided adaptive radiation boost after standard chemoradiation for adults with localized rectal adenocarcinoma to better target tumor cells and spare healthy tissue.

  Recruiting Phase 1 Fox Chase Cancer Center · Philadelphia, Pennsylvania · NCT07221058

• Cannabidiol (CBD) to prevent nerve damage from oxaliplatin chemotherapy

  This pilot will test whether hemp-derived cannabidiol (CBD) taken during oxaliplatin chemotherapy can prevent nerve damage in people with metastatic colorectal cancer.

  Recruiting Early Phase 1 Fox Chase Cancer Center · Philadelphia, Pennsylvania · NCT07167446

• Gemcitabine plus carboplatin after progression on enfortumab vedotin and pembrolizumab for advanced urothelial cancer

  This trial tests whether the chemotherapy combination gemcitabine and carboplatin can shrink or control advanced urothelial cancer in people whose cancer got worse after enfortumab vedotin plus pembrolizumab.

  Recruiting at 2 sites Phase 2 Fox Chase Cancer Center · Philadelphia, Pennsylvania and 1 other locations · NCT07043972

• Adaptive radiation therapy for locally advanced, unresectable pancreatic cancer.

  This trial will try adaptive radiation therapy to better target tumor cells and reduce side effects for people with locally advanced, unresectable pancreatic cancer.

  Recruiting Fox Chase Cancer Center · Philadelphia, Pennsylvania · NCT06984562

• Using Scrambler Therapy with Duloxetine for Chemotherapy-Induced Peripheral Neuropathy

  This study is testing if combining Scrambler therapy with duloxetine can help reduce pain in people who have chemotherapy-induced nerve damage.

  Recruiting Phase 2 Fox Chase Cancer Center · Philadelphia, Pennsylvania · NCT06914557

• Helping gynecologic cancer patients discuss sexual health with their doctors

  This study tests if an educational video and workbook can help gynecologic cancer patients talk more openly about sexual health with their doctors and improve their overall well-being.

  Recruiting Fox Chase Cancer Center · Philadelphia, Pennsylvania · NCT06904339

• Positive activities for Asian American cancer patients and their caregivers

  This study is testing a new program that encourages positive activities for Asian American cancer patients and their caregivers to see if it helps improve their mental well-being.

  Recruiting Fox Chase Cancer Center · Philadelphia, Pennsylvania · NCT06782581

• Exploring how older adults make cancer treatment decisions based on health assessments

  This study tests if giving older adults with cancer early access to their health information helps them make better treatment decisions and feel more satisfied with their choices.

  Recruiting Fox Chase Cancer Center · Philadelphia, Pennsylvania · NCT06652347

• Exploring genetic factors in retroperitoneal liposarcoma recurrences

  This study is trying to see if changes in the fat around a type of cancer called retroperitoneal liposarcoma can help explain why it comes back after treatment.

  Recruiting Fox Chase Cancer Center · Philadelphia, Pennsylvania · NCT06436846

• Improving follow-up care for cervical cancer in urban women

  This study is testing a new text and phone coaching program to help urban women with cervical cancer get the follow-up care they need after abnormal test results.

  Recruiting at 3 sites Fox Chase Cancer Center · New Brunswick, New Jersey and 2 other locations · NCT06416150

• Improving tumor detection before bladder cancer surgery

  This study is testing a new combination of tests to see if they can accurately find leftover tumors in bladder cancer patients before they have surgery.

  Recruiting at 2 sites Fox Chase Cancer Center · Omaha, Nebraska and 1 other locations · NCT06396533

• Combining Pacritinib and Talazoparib for Patients with Myeloproliferative Neoplasms Not Responding to JAK2 Therapy

  This study is testing a combination of two medications, pacritinib and talazoparib, to see if they can help patients with certain blood cancers who haven't responded to other treatments.

  Recruiting Phase 1 Fox Chase Cancer Center · Philadelphia, Pennsylvania · NCT06218628

• Using iron infusions to treat anemia in cancer patients before surgery

  This study tests if giving iron infusions to cancer patients before surgery can help improve their blood levels and reduce the need for blood transfusions during chemotherapy.

  Recruiting Phase 2 Fox Chase Cancer Center · Philadelphia, Pennsylvania · NCT05800600

• Dose-reduced chemotherapy for lung cancer patients with health issues

  This study is testing if a lower dose of chemotherapy can help lung cancer patients with other health issues feel better and manage their treatment safely.

  Recruiting Phase 2 Fox Chase Cancer Center · Philadelphia, Pennsylvania · NCT05800587

• Targeted radiation therapy for p16+ oropharynx cancer

  This study is testing a targeted radiation therapy for patients with a specific type of throat cancer to see if it helps them live longer and feel better after treatment.

  Recruiting Phase 2 Fox Chase Cancer Center · Philadelphia, Pennsylvania · NCT05800574

• Combining CBL0137 with Ipilimumab and Nivolumab for Melanoma Treatment

  This study is testing a new drug called CBL0137 combined with standard melanoma treatments Ipilimumab and Nivolumab to see if it’s safe and helps people with advanced melanoma.

  Recruiting Early Phase 1 Fox Chase Cancer Center · Philadelphia, Pennsylvania · NCT05498792

• Combining Neratinib and Fam-Trastuzumab Deruxtecan for Advanced Gastro-esophageal Cancer

  This study is testing a new combination of two cancer drugs to see if it can safely help people with advanced gastro-esophageal cancer that has a specific gene change.

  Recruiting at 3 sites Phase 1 Fox Chase Cancer Center · Palo Alto, California and 2 other locations · NCT05274048

• Alternative dosing schedule for cabozantinib in advanced kidney and neuroendocrine tumors

  This study is testing a new way to give cabozantinib to see if it helps people with advanced kidney cancer and neuroendocrine tumors feel better and stay safe while being treated.

  Recruiting Phase 2 Fox Chase Cancer Center · Philadelphia, Pennsylvania · NCT05263050

Quick answers

How many clinical trials run by Fox Chase Cancer Center are recruiting right now?

24, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in United States. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 9, Phase 1: 4, Early Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →